Estrgestdutant
Estrgestdutant
Common street names: StormLock, White Calm, SilkBlood, Quiet Fire
Classification
Advanced anti-inflammatory and tissue-repair regulator
Cytokine storm inhibitor
2D-material-mediated pharmaceutical
History and Development
Estrgestdutant was developed in 2358 CE by the Martian firm Helios-Varma Biomedica during the peak of the Mars City State War.
Early in the war, uncontrolled inflammatory responses were killing more soldiers than direct trauma.
Augmented troops were especially vulnerable. Their immune systems often overreacted to synthetic implants, nanites, and battlefield contaminants.
Traditional immunosuppressants left soldiers vulnerable to infection.
Estrgestdutant was created to solve this.
It became the first approved pharmaceutical to incorporate Two-Dimensional Material Agents.
These nano-thin carrier sheets allowed drugs to interact with immune signaling pathways with unprecedented precision.
It was fast-tracked and deployed in 2360 CE.
Civilian approval followed in 2363 CE.
Patents expired in 2458 CE.
Mechanism of Action
Estrgestdutant does not suppress immunity.
It modulates it.
Its 2D material agents bind selectively to:
• IL-6
• TNF-alpha
• Interferon gamma
• GM-CSF
These sheets act as programmable filters.
They absorb excess inflammatory signals while allowing baseline immune activity.
Simultaneously, embedded repair catalysts stimulate:
• fibroblast activity
• angiogenesis
• mitochondrial regeneration
• myelin repair
This makes Estrgestdutant both a regulator and a healer.
Forms and Dosage
Tablet Form
Standard sizes
• 100 mg micro-tablet
• 250 mg standard tablet
• 500 mg trauma tablet
• 750 mg combat tablet
Civilian dose
100 to 250 mg
Military dose
500 to 750 mg
Adi’s pharma implant can deliver continuous micro-dosing.
Injectable Liquid Form
Packaging
• 3 mL field vial
• 10 mL clinic vial
• 30 mL bulk vial
Concentration
25 mg per mL standard
60 mg per mL military
Delivered via injector, implant, or suit interface.
Duration
Onset
Injectable: 3 to 6 minutes
Oral: 15 to 25 minutes
Peak
1 to 2 hours
Therapeutic window
8 to 12 hours
Residual effects
Up to 24 hours
In augmented users: up to 36 hours
Effects
Primary Effects
• Suppression of cytokine storms
• Reduced swelling
• Stabilized immune response
• Accelerated wound closure
• Reduced scar formation
• Improved implant integration
Secondary Effects
• Reduced fever
• Increased stamina
• Improved oxygen efficiency
• Faster recovery from shock
Shelf Life
Standard
6 to 8 years sealed
After opening
12 months refrigerated
Expired batches lose targeting precision.
Old doses become blunt immunosuppressants.
Manufacturing
Original Developer
Helios-Varma Biomedica
Elysium Subsurface Complex, Mars
Current Major Producers
Mars
Helios Biocore
Cerberus Medical
Valles Therapeutics
Chendiuria
Sunreach BioForge
Titan and Europa
Licensed clones
Illicit labs produce crude versions.
Cost (Per Gram Equivalent)
Legitimate Markets
Tablets
Mars / Core Colonies
3 to 6 credits
Chendiuria
2 to 4 credits
Stations
5 to 9 credits
Injectable
Mars
12 to 20 credits
Stations
20 to 35 credits
Military bulk
0.9 credits
Illicit Markets
High-grade injectable
60 to 120 credits per gram
Expired stock
20 to 40 credits
Counterfeit
5 to 15 credits
Custom blends
200+ credits
Military Integration
Aditi "Adi" Nizhóní Peshlakai old armor
Manual auto-injectors
New Armor
Neural-linked pumps
Pharma Implant
Adaptive reservoirs
Asteria manages:
• immune telemetry
• nanite load
• tissue repair rate
• infection probability
Adi rarely develops dangerous inflammation.
Recreational Abuse
Estrgestdutant is abused in niche circles.
Street Uses
“White Drift”
Extreme relaxation and bodily calm
“Cold High”
Emotional flattening
“Reset Runs”
Used after stimulant binges
“Chrome Bath”
Used by heavy augment users
High doses produce:
• emotional detachment
• dissociation
• muted fear response
• mild euphoria
Addiction is psychological, not chemical.
Users crave the feeling of being “unbreakable.”
Risks and Drawbacks
Short-Term
• Masked infections
• Delayed fever response
• Overconfidence
Long-Term Abuse
• Immune recalibration drift
• Reduced pathogen sensitivity
• Increased cancer risk
• Autoimmune instability
Military monitors lifetime exposure.
Cultural Role
Estrgestdutant is considered a “professional’s drug.”
It is associated with:
• soldiers
• rescue crews
• extreme workers
• high-end clinics
Unlike Arteicridar, it is not casual.
Using it implies serious risk.
Rumors and Classified Variants
Known black projects
EGD-X
Combat regeneration enhancer
EGD-S
Interrogation stabilizer
EGD-Z
Zombie protocol for near-death troops
None officially exist.
According to records.
Common in the military, uncommon elsewhere.
Comments